New cathinone-derived designer drugs 3-bromomethcathinone and 3-fluoromethcathinone: studies on their metabolism in rat urine and human liver microsomes using GC-MS and LC-high-resolution MS and their detectability in urine

Mephedrone: use, subjective effects and health risks

(2011) Adam Winstock et al.   ADDICTION

Drugs of abuse screening in urine as part of a metabolite-based LC-MSn screening concept

(2011) Dirk K. Wissenbach et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

Automated Mass Spectral Deconvolution and Identification System for GC-MS Screening for Drugs, Poisons, and Metabolites in Urine

(2010) M. R. Meyer et al.   CLINICAL CHEMISTRY

Mephedrone (4-methylmethcathinone; ‘meow meow’): chemical, pharmacological and clinical issues

(2010) Fabrizio Schifano et al.   PSYCHOPHARMACOLOGY

Stereoselective differences in the cytochrome P450-dependent dealkylation and demethylenation of N-methyl-benzodioxolyl-butanamine (MBDB, Eden) enantiomers

(2009) Markus R. Meyer et al.   BIOCHEMICAL PHARMACOLOGY

Fluoromethcathinone, a new substance of abuse

(2009) R.P. Archer   FORENSIC SCIENCE INTERNATIONAL

Khat – a controversial plant

(2009) Erica E. Balint et al.   WIENER KLINISCHE WOCHENSCHRIFT

Metabolism and toxicological detection of the designer drug 4-chloro-2,5-dimethoxyamphetamine in rat urine using gas chromatography-mass spectrometry

(2008) Andreas H. Ewald et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

The Role of Human Hepatic Cytochrome P450 Isozymes in the Metabolism of Racemic 3,4-Methylenedioxy-Methamphetamine and Its Enantiomers

(2008) M. R. Meyer et al.   DRUG METABOLISM AND DISPOSITION